Sofinnova BioEquities Enhanced Master Fund, LP is a hedge fund based in Menlo Park, California. According to its most recent Form D, filed Oct 10, 2025, the fund has sold $41,545,600 of interests to 25 investors since its first sale in Oct 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, HedgeMountain classifies it as an emerging manager. Related persons named in the filing include Sofinnova Investments, Inc; Sofinnova BioEquities GP LLC.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $41,545,600Cumulative sales reported on Form D
- Investors
- 25
- First sale
- Oct 3, 2022
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Sofinnova Investments, Inc; Sofinnova BioEquities GP LLC
- Latest Form D
- Oct 10, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 54% of the 1,051 hedge funds based in California, and more than 42% of all 10,157 that report sales.